SANUWAVE Health, Inc. Common Stock
$4.55
$0.42 (+10.17%)
$4.11Day Range$4.55
Key Statistics
Market Cap
$35.53M
Shares Outstanding
8.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 8, 2008
Round Lot
100
Locale
US
Trading Data
Day Open
$4.14
Day High
$4.55
Day Low
$4.11
Volume
87.4K
VWAP
$4.45
Prev Close
$4.13
Transactions
--
Acc. Volume
--
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384155 employees9600 W. 76TH STREET, EDEN PRAIRIE, MN952-656-1029IPO Oct 8, 2008US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001417663
- Composite FIGI
- BBG000C33X21
- Share Class FIGI
- BBG001SV44J5
- Ticker Root
- SNWV
- SIC Code
- 3841
About SANUWAVE Health, Inc. Common Stock (SNWV) Stock
SANUWAVE Health, Inc. Common Stock (SNWV) closed the 2026-09-18 session at $4.55, up 10.17% versus the previous close (+0.42). The stock opened at $4.14 and traded between $4.11 and $4.55 during that session. Session trading volume was 87K shares. The volume-weighted average price (VWAP) is $4.45.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
SANUWAVE Health, Inc. Common Stock has a market capitalization of $35.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. SNWV is listed on the XNAS exchange. The company employs approximately 55 people. SANUWAVE Health, Inc. Common Stock is headquartered in EDEN PRAIRIE, MN. The recorded listing date is 2008-10-08.
On this page you can find market SNWV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.